Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06564363
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-19
Brief Title:
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma a Single Center Prospective Study
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The clinical trial was designed to determine the efficacy sensitivity and specificity of the IUrisure test compared to the gold standard cystoscopy and pathology in patients under monitoring for recurrence of urothelial carcinoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None